June 17, 2026 · Gynecologic oncology reports · DOI: 10.1016/j.gore.2026.102118

The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatment

Listen to this summary

The authors aimed to evaluate the impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) on the sexual wellbeing of ovarian cancer survivors. Their study found that a significant majority of patients reported negative changes in sexual wellbeing post-treatment, with only a third receiving relevant healthcare support, which was associated with higher sexual satisfaction. The findings highlight the need for improved attention to sexual health in the survivorship care of ovarian cancer patients.

Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, Kathleen Pawlikowski, Vladislav Kovalik, Sergei Iugai, Carol Nieroda, Vadim Gushchin, Teresa Diaz-Montes

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play